WO2005079751A3 - Oral pharmaceutical compositions of candesartan cilexetil - Google Patents

Oral pharmaceutical compositions of candesartan cilexetil Download PDF

Info

Publication number
WO2005079751A3
WO2005079751A3 PCT/IB2005/000148 IB2005000148W WO2005079751A3 WO 2005079751 A3 WO2005079751 A3 WO 2005079751A3 IB 2005000148 W IB2005000148 W IB 2005000148W WO 2005079751 A3 WO2005079751 A3 WO 2005079751A3
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutical compositions
candesartan cilexetil
oral pharmaceutical
cilexetil
candesartan
Prior art date
Application number
PCT/IB2005/000148
Other languages
French (fr)
Other versions
WO2005079751A2 (en
Inventor
Romi Barat Singh
Girish K Karanth
Vishnubhotla Naga Prasad
Sanjeev Kumar Sethi
Original Assignee
Ranbaxy Lab Ltd
Romi Barat Singh
Girish K Karanth
Vishnubhotla Naga Prasad
Sanjeev Kumar Sethi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd, Romi Barat Singh, Girish K Karanth, Vishnubhotla Naga Prasad, Sanjeev Kumar Sethi filed Critical Ranbaxy Lab Ltd
Priority to EP05702309A priority Critical patent/EP1711168A2/en
Publication of WO2005079751A2 publication Critical patent/WO2005079751A2/en
Publication of WO2005079751A3 publication Critical patent/WO2005079751A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The present invention relates to pharmaceutical compositions of candesartan cilexetil that include fatty substances and processes for their preparation.
PCT/IB2005/000148 2004-01-23 2005-01-21 Oral pharmaceutical compositions of candesartan cilexetil WO2005079751A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP05702309A EP1711168A2 (en) 2004-01-23 2005-01-21 Oral pharmaceutical compositions of candesartan cilexetil

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN127/DEL/2004 2004-01-23
IN127DE2004 2004-01-23

Publications (2)

Publication Number Publication Date
WO2005079751A2 WO2005079751A2 (en) 2005-09-01
WO2005079751A3 true WO2005079751A3 (en) 2006-03-30

Family

ID=34878773

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2005/000148 WO2005079751A2 (en) 2004-01-23 2005-01-21 Oral pharmaceutical compositions of candesartan cilexetil

Country Status (2)

Country Link
EP (1) EP1711168A2 (en)
WO (1) WO2005079751A2 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI494134B (en) * 2006-06-20 2015-08-01 Siegfried Generics Int Ag Composition granule and tablet containing candesartan cilexetil and process to fabricate the tablet
AU2007293727A1 (en) * 2006-09-05 2008-03-13 Astrazeneca Ab Pharmaceutical composition comprising candesartan cilexetil
WO2008045006A1 (en) * 2006-10-11 2008-04-17 Fako Ilaclari A. S. Formulations of candesartan
EP2099431B1 (en) * 2006-11-28 2013-06-05 Laboratorios Liconsa, S.A. Stabilized solid pharmaceutical composition of candesartan cilexetil
WO2008084504A2 (en) * 2007-01-12 2008-07-17 Rubicon Research Private Limited Pharmaceutical compositions of angiotensin ii receptor blockers
EP1952806A1 (en) 2007-02-01 2008-08-06 Helm AG Process for the preparation of adsorbates of candesartan
PL384680A1 (en) * 2007-03-28 2008-09-29 Zak & Lstrok Ady Farmaceutyczn Pharmaceutical composition containing cylexyethyl candesarthan and its production method
RU2010104960A (en) * 2007-08-01 2011-09-10 Тева Фармасьютикал Индастриес Лтд. (Il) PHARMACEUTICAL COMPOSITION OF CANDESARTAN
DE102007052070A1 (en) 2007-10-30 2009-05-07 Tiefenbacher Pharmachemikalien Alfred E. Tiefenbacher Gmbh & Co. Kg candesartancilexetil
PT2165702E (en) * 2008-09-17 2012-02-07 Helm Ag Stable and readily dissolved compositions of candesartan cilexetil prepared with wet granulation
DE102008059206A1 (en) 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmaceutical dosage form containing nifedipine or nisoldipine and an angiotensin II antagonist and / or a diuretic
ES2364011B1 (en) 2009-11-20 2013-01-24 Gp Pharm, S.A. CAPSULES OF PHARMACEUTICAL ACTIVE AND ESTERS OF POLYINSATURATED FATTY ACIDS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES.
ES2556985T3 (en) 2011-01-11 2016-01-21 Capsugel Belgium Nv New hard capsules comprising pululane
BR112014027618A2 (en) 2012-05-07 2017-06-27 Bayer Pharma AG A process for the manufacture of a pharmaceutical dosage form comprising nifedipine and candesartan cilexetil.
CN103127012B (en) * 2013-02-17 2015-04-22 杭州澳医保灵药业有限公司 Ebastine dispersible tablet and preparation method thereof
BR112019021396A2 (en) 2017-04-14 2020-04-28 Capsugel Belgium Nv pullulan manufacturing process
CA3059527A1 (en) 2017-04-14 2018-10-18 Capsugel Belgium Nv Pullulan capsules
CN117442577B (en) * 2023-12-21 2024-03-15 山东则正医药技术有限公司 Candesartan cilexetil microchip and preparation method and application thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0546358A2 (en) * 1991-11-20 1993-06-16 Takeda Chemical Industries, Ltd. Pharmaceutical compositions with angiotensin-II-antagonistic activity
WO1999056734A2 (en) * 1998-05-06 1999-11-11 Hexal Ag Transdermal therapeutic system for the administration of candesartan
EP1153613A1 (en) * 1999-02-19 2001-11-14 Takeda Chemical Industries, Ltd. Percutaneous absorption preparations of compound having angiotensin ii receptor antagonism
EP1312379A1 (en) * 2000-08-25 2003-05-21 Takeda Chemical Industries, Ltd. Fibrinogen lowering agents

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0546358A2 (en) * 1991-11-20 1993-06-16 Takeda Chemical Industries, Ltd. Pharmaceutical compositions with angiotensin-II-antagonistic activity
WO1999056734A2 (en) * 1998-05-06 1999-11-11 Hexal Ag Transdermal therapeutic system for the administration of candesartan
EP1153613A1 (en) * 1999-02-19 2001-11-14 Takeda Chemical Industries, Ltd. Percutaneous absorption preparations of compound having angiotensin ii receptor antagonism
EP1312379A1 (en) * 2000-08-25 2003-05-21 Takeda Chemical Industries, Ltd. Fibrinogen lowering agents

Also Published As

Publication number Publication date
WO2005079751A2 (en) 2005-09-01
EP1711168A2 (en) 2006-10-18

Similar Documents

Publication Publication Date Title
WO2005079751A3 (en) Oral pharmaceutical compositions of candesartan cilexetil
WO2008128115A3 (en) Low-dose doxepin formulations
IL195491A (en) Pharmaceutical compositions of tmc278 and processes for their preparation
WO2008066899A3 (en) Nanoparticulate formulations and methods for the making and use thereof
SI1752443T1 (en) New crystalline form V of agometaline, the process for its preparation and the pharmaceutical compositions containing it
IL184114A0 (en) Use of diketodithiopiperazine antibiotics for the preparation of antiangiogenic pharmaceutical compositions
IL176519A0 (en) Directly compressible pharmaceutical composition for the oral administration of cci-779
SI1695709T1 (en) Crystalline form gamma-d of the chlorohydrate of ivabradine, process for its preparation and pharmaceutical compositions containing it
WO2006131591A3 (en) An entacapone-containing oral dosage form
WO2005070398A3 (en) Pharmaceutical compositions of candesartan cilexetil stabilized with co-solvents
WO2005084648A8 (en) Pharmaceutical compositions comprising candesartan cilexetil
EP1637167A3 (en) New injectable formulations containing progesterone
WO2008054808A3 (en) Elvucitabine pharmaceutical compositions
ZA200805011B (en) Water-soluble benzoazepine compound and its pharmaceutical composition
EP2142549A4 (en) Adenosine derivatives, method for the synthesis thereof, and the pharmaceutical compositions for the prevention and treatment of the inflammatory diseases containing the same as an active ingredient
IL183986A0 (en) Pharmaceutical compounds and compositions
WO2007025146A3 (en) Balsalazide formulations and manufacture and use thereof
IL178067A0 (en) Pharmaceutical dosage forms and compositions
EP2644614A3 (en) Solid state forms of 5-azacytidine and processes for preparation thereof
WO2007067784A3 (en) Liposomal compositions
IL183930A0 (en) Use of cladribine for preparation of pharmaceutical compositions
IL179337A0 (en) Pharmaceutical compositions for the treatment of pruritus
WO2006046871A3 (en) Peri-operative composition comprising lactobacillus rhamnosus
WO2008033930A3 (en) Vinca derivatives
IL177735A0 (en) Combined pharmaceutical composition for the inhibition of the decline of cognitive functions

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2005702309

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 4234/DELNP/2006

Country of ref document: IN

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Ref document number: DE

WWP Wipo information: published in national office

Ref document number: 2005702309

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2005702309

Country of ref document: EP